Current and promising therapeutic options for Dravet syndrome-Reference-Cited by-同舟云学术

Current and promising therapeutic options for Dravet syndrome

Published:2022-09-21 Issue:15 Volume:23 Page:1727-1736
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Riva Antonella¹²,D’Onofrio Gianluca¹²,Amadori Elisabetta¹²,Tripodi Domenico³,Balagura Ganna⁴,Iurilli Valentina⁵,Vari Maria Stella¹,Verrotti Alberto⁶,Striano Pasquale¹²^ORCID

Affiliation:

1. Pediatric Neurology and Muscular Diseases Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy

2. Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy

3. Department of Medical, Oral and Biotechnological Sciences, University of Chieti, Genoa, Italy

4. Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit (VU), de Boelelaan, Amsterdam, Netherlands

5. Pharmacy, IRCCS Istituto Giannina Giannina Gaslini, Genoa, Italy

6. Department of Pediatrics, University of Perugia, Perugia, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2127089

Reference105 articles.

1. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology

2. The core Dravet syndrome phenotype

3. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions